Korea FDA Highlights Efforts To Bring Orphan Drugs To Market; Novo Nordisk, Alexion, Merck Serono Gain Approvals
This article was originally published in PharmAsia News
Executive Summary
SEOUL - Korea FDA is promoting its work to bring orphan drugs to market in South Korea, and for the first time the agency released the names and makers of approved drugs in a press report to the media. Of the 23 biological drugs approved by KFDA during the first half of 2010, four were orphan drugs for the treatment of rare diseases